Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-05

Clinical Trial Update: Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating pharmacokinetic comparability of benralizumab delivered via accessorized pre-filled syringe versus autoinjector in healthy volunteers; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma, Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-07-05